Stock Track | Bicycle Therapeutics Plunges 6% Following RBC Downgrade and Target Price Cut

Stock Track

2025/10/31

Shares of Bicycle Therapeutics Limited (BCYC) plummeted 6.05% in pre-market trading on Friday, following a significant downgrade from RBC Capital Markets. The sharp decline comes as investors react to the change in analyst sentiment and a substantial reduction in the stock's target price.

RBC Capital Markets lowered its rating on Bicycle Therapeutics from Outperform to Sector Perform, signaling a less optimistic outlook for the company. Moreover, the financial institution drastically cut its target price for BCYC from $27 to $11, representing a 59% reduction. This substantial downward revision in the target price suggests that RBC analysts have reassessed their expectations for Bicycle Therapeutics' future performance, potentially due to concerns about the company's growth prospects or market position in the competitive healthcare sector.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1148629238"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1148629238\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1148629238?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-31 21:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1148629238","market":"hk","top_or_hot":-1,"title":"Stock Track | Bicycle Therapeutics Plunges 6% Following RBC Downgrade and Target Price Cut","media":"Stock Track","content":"<p>Shares of Bicycle Therapeutics Limited (BCYC) plummeted 6.05% in pre-market trading on Friday, following a significant downgrade from RBC Capital Markets. The sharp decline comes as investors react to the change in analyst sentiment and a substantial reduction in the stock's target price.</p>\n\n<p>RBC Capital Markets lowered its rating on Bicycle Therapeutics from Outperform to Sector Perform, signaling a less optimistic outlook for the company. Moreover, the financial institution drastically cut its target price for BCYC from $27 to $11, representing a 59% reduction. This substantial downward revision in the target price suggests that RBC analysts have reassessed their expectations for Bicycle Therapeutics' future performance, potentially due to concerns about the company's growth prospects or market position in the competitive healthcare sector.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Bicycle Therapeutics Plunges 6% Following RBC Downgrade and Target Price Cut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Bicycle Therapeutics Plunges 6% Following RBC Downgrade and Target Price Cut\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2025-10-31 21:35</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shares of Bicycle Therapeutics Limited (BCYC) plummeted 6.05% in pre-market trading on Friday, following a significant downgrade from RBC Capital Markets. The sharp decline comes as investors react to the change in analyst sentiment and a substantial reduction in the stock's target price.</p>\n\n<p>RBC Capital Markets lowered its rating on Bicycle Therapeutics from Outperform to Sector Perform, signaling a less optimistic outlook for the company. Moreover, the financial institution drastically cut its target price for BCYC from $27 to $11, representing a 59% reduction. This substantial downward revision in the target price suggests that RBC analysts have reassessed their expectations for Bicycle Therapeutics' future performance, potentially due to concerns about the company's growth prospects or market position in the competitive healthcare sector.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BCYC","symbol_name":"Bicycle Therapeutics Limited","start_time":0,"source_url":"","article_id":"1148629238","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1148629238","pubTimestamp":1761917703,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Bicycle Therapeutics Limited (BCYC) plummeted 6.05% in pre-market trading on Friday, following a significant downgrade from RBC Capital Markets. The sharp decline comes as investors react...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BCYC":"Bicycle Therapeutics Limited"},"translate_title":"个股追踪|加拿大皇家银行下调评级和下调目标价后，Bicycle Therapeutics暴跌6%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BCYC":1},"content_text":"Shares of Bicycle Therapeutics Limited (BCYC) plummeted 6.05% in pre-market trading on Friday, following a significant downgrade from RBC Capital Markets. The sharp decline comes as investors react to the change in analyst sentiment and a substantial reduction in the stock's target price.\nRBC Capital Markets lowered its rating on Bicycle Therapeutics from Outperform to Sector Perform, signaling a less optimistic outlook for the company. Moreover, the financial institution drastically cut its target price for BCYC from $27 to $11, representing a 59% reduction. This substantial downward revision in the target price suggests that RBC analysts have reassessed their expectations for Bicycle Therapeutics' future performance, potentially due to concerns about the company's growth prospects or market position in the competitive healthcare sector.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}